BAUSCH HEALTH COS INC (BHC) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:BHC • CA0717341071

5.74 USD
+0.15 (+2.68%)
At close: Jan 30, 2026
5.75 USD
+0.01 (+0.17%)
After Hours: 1/30/2026, 8:04:00 PM
Fundamental Rating

4

Overall BHC gets a fundamental rating of 4 out of 10. We evaluated BHC against 190 industry peers in the Pharmaceuticals industry. BHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BHC is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BHC had positive earnings in the past year.
  • In the past year BHC had a positive cash flow from operations.
  • BHC had negative earnings in each of the past 5 years.
  • BHC had a positive operating cash flow in 4 of the past 5 years.
BHC Yearly Net Income VS EBIT VS OCF VS FCFBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.35%, BHC is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • The Return On Invested Capital of BHC (7.44%) is better than 84.74% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BHC is significantly below the industry average of 12.83%.
  • The last Return On Invested Capital (7.44%) for BHC is above the 3 year average (5.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROIC 7.44%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.98%
ROIC(5y)5.41%
BHC Yearly ROA, ROE, ROICBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.61%, BHC is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • BHC's Operating Margin of 20.68% is amongst the best of the industry. BHC outperforms 87.37% of its industry peers.
  • BHC's Operating Margin has improved in the last couple of years.
  • BHC has a Gross Margin of 70.67%. This is in the better half of the industry: BHC outperforms 77.89% of its industry peers.
  • BHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
BHC Yearly Profit, Operating, Gross MarginsBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

  • BHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for BHC has been increased compared to 1 year ago.
  • BHC has more shares outstanding than it did 5 years ago.
  • BHC has a better debt/assets ratio than last year.
BHC Yearly Shares OutstandingBHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BHC Yearly Total Debt VS Total AssetsBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

  • BHC has an Altman-Z score of 0.24. This is a bad value and indicates that BHC is not financially healthy and even has some risk of bankruptcy.
  • BHC has a Altman-Z score (0.24) which is in line with its industry peers.
  • BHC has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as BHC would need 19.41 years to pay back of all of its debts.
  • BHC's Debt to FCF ratio of 19.41 is fine compared to the rest of the industry. BHC outperforms 76.32% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Altman-Z 0.24
ROIC/WACC1.09
WACC6.8%
BHC Yearly LT Debt VS Equity VS FCFBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that BHC should not have too much problems paying its short term obligations.
  • BHC has a Current ratio of 1.30. This is in the lower half of the industry: BHC underperforms 76.84% of its industry peers.
  • BHC has a Quick Ratio of 1.30. This is a bad value and indicates that BHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.97, BHC is not doing good in the industry: 78.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.97
BHC Yearly Current Assets VS Current LiabilitesBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. Growth

3.1 Past

  • BHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.33%.
  • The Earnings Per Share has been decreasing by -2.91% on average over the past years.
  • The Revenue has been growing slightly by 5.86% in the past year.
  • Measured over the past years, BHC shows a small growth in Revenue. The Revenue has been growing by 2.28% on average per year.
EPS 1Y (TTM)1.33%
EPS 3Y-5.37%
EPS 5Y-2.91%
EPS Q2Q%2.65%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y4.5%
Revenue growth 5Y2.28%
Sales Q2Q%6.81%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.58% on average over the next years.
  • The Revenue is expected to decrease by -0.40% on average over the next years.
EPS Next Y5.12%
EPS Next 2Y6.66%
EPS Next 3Y-1.71%
EPS Next 5Y-3.58%
Revenue Next Year6.13%
Revenue Next 2Y5.11%
Revenue Next 3Y3.03%
Revenue Next 5Y-0.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHC Yearly Revenue VS EstimatesBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC Yearly EPS VS EstimatesBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

9

4. Valuation

4.1 Price/Earnings Ratio

  • BHC is valuated cheaply with a Price/Earnings ratio of 1.50.
  • 98.95% of the companies in the same industry are more expensive than BHC, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BHC to the average of the S&P500 Index (28.30), we can say BHC is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 1.34, the valuation of BHC can be described as very cheap.
  • BHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. BHC is cheaper than 98.95% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.57, BHC is valued rather cheaply.
Industry RankSector Rank
PE 1.5
Fwd PE 1.34
BHC Price Earnings VS Forward Price EarningsBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BHC is cheaper than 93.68% of the companies in the same industry.
  • BHC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BHC is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.96
EV/EBITDA 6.61
BHC Per share dataBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • BHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BHC may justify a higher PE ratio.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y-1.71%

0

5. Dividend

5.1 Amount

  • BHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BAUSCH HEALTH COS INC / BHC FAQ

What is the ChartMill fundamental rating of BAUSCH HEALTH COS INC (BHC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BHC.


Can you provide the valuation status for BAUSCH HEALTH COS INC?

ChartMill assigns a valuation rating of 9 / 10 to BAUSCH HEALTH COS INC (BHC). This can be considered as Undervalued.


Can you provide the profitability details for BAUSCH HEALTH COS INC?

BAUSCH HEALTH COS INC (BHC) has a profitability rating of 6 / 10.


Can you provide the financial health for BHC stock?

The financial health rating of BAUSCH HEALTH COS INC (BHC) is 2 / 10.